2022•SSRN Electronic JournalOpen access

Protective Efficacy of 6-Week Regimen of Rifapentine Plus Isoniazid for Latent Tuberculosis Infection Treatment Among Individuals With Prior Tuberculosis Suggested By Radiography Abnormalities: 2-Year Follow-Up of a Randomized Controlled Trial

Haoran Zhang, Henan Xin, Ying Du, Shouguo Pan, Jianmin Liu, Xuefang Cao, Ling Guan, Fei Shen, Zisen Liu, Bin Zhang, Dakuan Wang, Boxuan Feng, Xueling Guan, Yijun He, Yongpeng He, Zhanjiang Zhang, Jiaoxia Yan, Qi Jin, Lei Gao, anon Sudy Team

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Rifapentine, Isoniazid, Regimen, Medicine, Randomized controlled trial, Tuberculosis, Latent tuberculosis, Internal medicine

Back to paper search Browse research topics Original source

Protective Efficacy of 6-Week Regimen of Rifapentine Plus Isoniazid for Latent Tuberculosis Infection Treatment Among Individuals With Prior Tuberculosis Suggested By Radiography Abnormalities: 2-Year Follow-Up of a Randomized Controlled Trial — Research Paper | ScholarLens